Lederle's Tri-Immunol case
Executive Summary
U.S. Supreme Court declines to consider case in which an Idaho Ninth Circuit Court jury awarded $1.1 mil. to a boy paralyzed after receiving Lederle's diphtheria-tetanus-pertussis vaccine Tri-Immounol in 1979. The firm's petition for a writ of certiorari was denied without comment on March 7. The Supreme Court previously agreed to review another Lederle vaccine injury case, which involves FDA liability for approving Lederle's polio vaccine Orimmune ("The Pink Sheet" Jan. 18, T&G-1).